• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 30 Results
Document Number K160793
 
 1 
 2 
 3 
 > 
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Origin Diagnostics, Origin Instant Dip Drug Test (MDMA)  
CR210101 K160793 Methylenedioxymethamphetamine (MDMA) Toxicology / TDM WAIVED 01/19/2022
Origin Diagnostics, Origin Instant Dip Drug Test (EDDP)  
CR210101 K160793 Methadone metabolite (EDDP) Toxicology / TDM WAIVED 01/19/2022
Origin Diagnostics, Origin Instant Dip Drug Test (Notriptyline)  
CR210101 K160793 Nortriptyline Toxicology / TDM WAIVED 01/19/2022
Hospital Connect Inc. Serenity Test Cup  
CR200464 K160793 Tricyclic antidepressants Toxicology / TDM WAIVED 07/02/2021
Hospital Connect Inc. Serenity Test Cup  
CR200464 K160793 Methylenedioxymethamphetamine (MDMA) Toxicology / TDM WAIVED 07/02/2021
Hospital Connect Inc. Serenity Test Cup  
CR200464 K160793 Methadone metabolite (EDDP) Toxicology / TDM WAIVED 07/02/2021
Origin Diagnostics Origin Instant Drug Test (EDDP)  
CR190725 K160793 Methadone metabolite (EDDP) Toxicology / TDM WAIVED 01/06/2020
Origin Diagnostics Origin Instant Drug Test (MDMA)  
CR190725 K160793 Methylenedioxymethamphetamine (MDMA) Toxicology / TDM WAIVED 01/06/2020
Origin Diagnostics Origin Instant Drug Test (Nortriptyline)  
CR190725 K160793 Tricyclic antidepressants Toxicology / TDM WAIVED 01/06/2020
Clinical Reference Laboratory, CRLstat Onsite EDDP Cup Test  
CR190326 K160793 Methadone metabolite (EDDP) Toxicology / TDM WAIVED 07/02/2019

-
-